ClinicalTrials.gg

Arrowhead Pharmaceuticals clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 51 studies whose lead sponsor is Arrowhead Pharmaceuticals or one of 1 company grouped under it. 8 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 10, 2026.

Our grouping of 2 registry names, not the registry’s. See them and correct one ↓

Compare Arrowhead Pharmaceuticals with Eli Lilly and AstraZeneca →

Pipeline: 8 programs

Each counted once: 8 with a study Arrowhead Pharmaceuticals leads registered in the last two years.

  • Phase 1
  • Phase 2
  • Phase 3

The 2 phase-3 programs — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Arrowhead Pharmaceuticals’ own registered studies; Arrowhead Pharmaceuticals’ own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Arrowhead Pharmaceuticals’ studies test, most open studies first — 5 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

6 of Arrowhead Pharmaceuticals’ studies under way reach primary completion within a year, 1 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. 1D
  3. J’27
  4. 1F
  5. M
  6. A
  7. M
  8. 1J
  9. 1J
  10. 1A
  11. S
  12. 1O
  13. N

Add all 6 to your calendar (.ics) → With an account.

All 51 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now816%Recruiting 7 · Not yet recruiting 1
  • Under way, not recruiting48%
  • Completed2345%
  • Stopped early1529%Terminated 12 · Withdrawn 3
  • Status unknown or other12%

Phase

  • Phase 228
  • Phase 125
  • Phase 38

Where

  • New Zealand28
  • Australia26
  • Canada19
  • United States18
  • Germany14
  • Spain11

Over the years

  1. 08
  2. 09
  3. 10
  4. 11
  5. 12
  6. 13
  7. 14
  8. 715
  9. 16
  10. 17
  11. 18
  12. 19
  13. 20
  14. 21
  15. 22
  16. 23
  17. 24
  18. 25
  19. 426

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Arrowhead Pharmaceuticals.

  • Arrowhead Pharmaceuticals
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    50 studies
  • Calando Pharmaceuticals
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Studies

Recruiting first, then most recently updated. Showing 50 of 51. Browse all 51 →